[e-drug] Content of Prescrire International, October 2008 Volume 17 N° 97

E-DRUG: Content of Prescrire International, October 2008 Volume 17 N° 97
------------------------------------------------------------------------------------------------------

Prescrire International is the English language edition of the reference French journal la revue Prescrire. It contains comparative evaluation of new drug interventions, reviews of adverse effects, and papers on drug policy issues.

Prescrire International is totally funded by subscribers, with no support from pharmaceutical industry or government. It is published six times a year and health professionals in low income countries can also benefit from the journal thanks to Solidarity Subscription Rates. Drug companies are excluded from applying to Solidarity Rates.

Contents of Prescrire International,

October 2008 Volume 17 N° 97

Editorial _____________________

. Thanks, but no thanks
  Regulators encourage overmedication

New Products _____________________
. Ziconotide (severe pain)
  Limited analgesic efficacy, too many adverse effects

. Ramelteon (insomnia)
  No role for risky placebos
  Melatonin: licensed, but still no proof of efficacy

. Fluoxetine (depression in children)
  Too many uncertainties

. Vildagliptin and vildagliptin/metformin (type 2 diabetes)
  Same limited efficacy as sitagliptin

. Pioglitazone (type 2 diabetes)
   No glitazones with or without insulin
   Editors' opinion: Do not use glitazones either alone or in combination
   for treatment of diabetes

. Miconazole mucoadhesive gingival tablet (oropharyngeal candidiasis)
  New form of tablet, no proven advantages

. Methoxy polyethylene glycol-epoetin beta (symptomatic anaemia)
  Risk of cardiovascular disorders

. Risedronic acid (osteoporosis in men)
  No fewer symptomatic fractures

. Verteporfin (neovascular forms of ARMD)
  A welcome restriction of indications

. Piroxicam (restriction of indications)
  Only half-measures

. Common stems - INN: -vudine and -taxel

. Teriparatide (osteoporosis in men)
  No evidence of efficacy, frequent adverse effects

. Dexrazoxane
  Possibly helpful for preventing anthracycline cardiotoxicity

. Timothy pollen oral lyophilisate (hay fever)
  Not acceptable

. Rotarix° packaging
  More improvement needed

Adverse effects _______________________

. Drug-induced taste disorders

. Varenicline: a British review

. Dopamine agonists: pathological gambling and hypersexuality

. Osteonecrosis of the jaw due to bisphosphonates

. Ischaemic colitis and neuroleptics

. Hypertrichosis in children treated with steroids

. Acute adrenal failure: inhaled steroids too

. Oseltamivir: gastrointestinal bleeding

. Renal failure and gadolinium

. Levofloxacin and glycaemic disorders

. Vertebroplasty and adverse effects of cement

Reviews _____________

. Sleep complaints
  Avoid the use of sleeping pills

. Prescrire's advice: How to help a patient who complains of poor-quality
  sleep and who has not yet been treated

. Agitation in Alzheimer's disease: no to donepezil
  Social and behaviour management is best

. Higher type 2 diabetes-related mortality when HbA1c levels are too
  low. HbA1c of 7% is best

. Do not use bisphosphonate therapy indefinitely for fracture
  prevention

  No longer than 5 years

. Surgery in asymptomatic carotid stenosis: no advantage
  A meta-analysis of about 5000 patients

Outlook _______

. Editorial: Human guinea pigs

. Direct-to-consumer advertising of prescription drugs: harmful and difficult to regulate

. Standing up to salt industry lobbies

. Forum - Kept in the dark about dangerous medicines